Multimodal treatments versus pharmacotherapy alone in children with psychiatric disorders: Implications of access, effectiveness, and contextual treatment

Pediatric Drugs

Volumn 11, Issue 3, 2009, Pages 165-169

  Reeves, Gloria ^a,b   Anthony, Bruno ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; DEXAMPHETAMINE; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; METHYLPHENIDATE; PEMOLINE; PLACEBO;

ADOLESCENT; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL TRIAL; COGNITIVE THERAPY; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; DRUG DOSE TITRATION; EVIDENCE BASED MEDICINE; FAMILY FUNCTIONING; FOLLOW UP; HEALTH CARE ACCESS; HUMAN; INTERMETHOD COMPARISON; MAJOR DEPRESSION; MENTAL HEALTH CARE; NOTE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CAREGIVERS; CHILD; COMBINED MODALITY THERAPY; HUMANS; MENTAL DISORDERS; PSYCHOTHERAPY;

EID: 65949087016     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00148581-200911030-00002     Document Type: Note

References (29)

1. Report of the Working Group on Psychotropic Medications for Children and Adolescents: psychopharmacological, psychosocial, and combined interventions for childhood disorders: evidence base, contextual factors, and future directions [online]. Available from URL: http://www.apa.org/pi/cyf/ childmeds.pdf [Accessed 2008 Oct 15]
2. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2007 Feb; 46 (2): 267-83
3. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. JAm Acad Child Adolesc Psychiatry 2007 Jan; 46 (1): 107-25
4. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 2007 Nov; 46 (11): 1503-26
5. Ma J, Lee KV, Stafford RS. Depression treatment during outpatient visits by U.S. children and adolescents. J Adolesc Health 2005 Dec; 37 (6): 434-42
6. Leigh H, Stewart D, Mallios R. Mental health and psychiatry training in primary care residency programs: part II. What skills and diagnoses are taught, how adequate, and what affects training directors' satisfaction? Gen Hosp Psychiatry 2006 May-Jun; 28 (3): 195-204
7. Richardson LP, Lewis CW, Casey-Goldstein M, et al. Pediatric primary care providers and adolescent depression: a qualitative study of barriers to treatment and the effect of the black box warning. J Adolesc Health 2007 May; 40 (5): 433-9
8. Kim WJ. Child and adolescent psychiatry workforce: a critical shortage and national challenge. Acad Psychiatry 2003 Winter; 27 (4): 277-82
9. Foster EM, Jensen PS, Schlander M, et al. Treatment for ADHD: is more complex treatment cost-effective for more complex cases? Health Serv Res 2007 Feb; 42: 165-82
10. Vitiello B. An update on publicly funded multisite trials in pediatric psychopharmacology. Child Adolesc Psychiatric Clin N Am 2006; 15: 1-12
11. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention deficit/hyperactivity disorder (ADHD). Arch Gen Psychiatry 1999a Dec; 56 (12): 1073-86
12. March J, Silva S, Petrycki S, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. JAMA 2004 Aug; 292 (7): 807-20
13. Greenhill LL, Abikoff HB, Arnold LE, et al. Medication treatment strategies in the MTA study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry 1996 Oct; 35 (10): 1304-13
14. Pelham WE, Hoza B. Intensive treatment: a summer treatment program for children with ADHD. In: Hibbs ED, Jensen PS, editors. Psychosocial treatments for empirically-based strategies for clinical practice. New York: American Psychological Association, 1996: 311-40
15. Conners CK, Epstein JN, March JS, et al. Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. J Am Acad Child Adolesc Psychiatry 2001 Feb; 40 (2): 159-67
16. Wells KC, Chi TC, Hinshaw SP, et al. Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder. J Consult Clin Psychol 2006 Aug; 74 (4): 649-57
17. Patterson GR, Reid JB, Dishion TJ. Antisocial boys: Vol. 4. A social interactional approach. Eugene (OR): Castalia, 1992
18. Pierce EW, Ewing LJ, Campbell SB. Diagnostic status and symptomatic behavior of hard-to-manage preschool children in middle childhood and early adolescence. J Clin Child Psychol 1999 Mar; 28 (1): 44-57
19. The MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics 2004; 113 (4): 754-61
20. The MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 2004; 113 (4): 762-9
21. Jensen PS, Arnold LE, Swanson JM, et al. 3-year follow-up of the NIMH MTA Study. J Am Acad Child Adolesc Psychiatry 2007 Aug; 46 (8): 988-1002
22. Molina BS, Flory K, Hinshaw SP, et al. Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry 2007 Aug; 46 (8): 1028-40
23. Swanson JM, Hinshaw SP, Arnold LE, et al. Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. J Am Acad Child Adolesc Psychiatry 2007 Aug; 46 (8): 1003-14
24. The Treatment for Adolescents with Depression Study Team. Treatment for Adolescents with Depression Study (TADS): rationale, design, and methods. J Am Acad Child Adolesc Psychiatry 2003 May; 42 (5): 531-42
25. March J, Silva S, Vitiello B, et al. The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks. J Am Acad Child Adolesc Psychiatry 2006 Dec; 45 (12): 1393-403
26. Kennard B, Silva S, Vitiello B, et al. Remission and residual symptoms after short-term treatment in the treatment of adolescents with depression study. J Am Acad Child Adolesc Psychiatry 2006; 45 (12): 1404-11
27. Hollon SD, Garber J, Shelton RC. Treatment of depression in adolescents with cognitive behavior therapy and medications: a commentary on the TADS project. Cogn Behav Pract 2005; 12 (2): 149-55
28. March JS, Silva S, Petrycki S, et al. The Treatment for Adolescents with Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry 2007 Oct; 64 (10): 1132-44
29. Hack S, Chow B. Pediatric psychotropic medication compliance: a literature review and research-based suggestions for improving treatment compliance. J Child Adolesc Psychopharmacol 2001 Spring; 11 (1): 59-67